Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001104659-25-012911·Rubric Capital Management LP
Schedule 13G ownership disclosure
Trevi Therapeutics Inc
Common Stock, $0.001 par value per share ("Common Stock") · CUSIP: 89532M101
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Rubric Capital Management LP
Shares: 4,205,129.00 · Class: 4.71%
- David Rosen
Shares: 4,205,129.00 · Class: 4.71%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-012911
- Form type
- SCHEDULE 13G/A
- Filer
- Rubric Capital Management LP
- CIK
- CIK 1687509
- Filed
- Feb 13, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership